SWAV - ShockWave Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
Total Revenue
25,944
12,263
1,719
Cost of Revenue
12,482
7,250
2,836
Gross Profit
13,462
5,013
-1,117
Operating Expenses
Research Development
26,062
22,698
17,963
Selling General and Administrative
32,015
23,515
11,785
Total Operating Expenses
58,077
46,213
29,748
Operating Income or Loss
-44,615
-41,200
-30,865
Interest Expense
838
401
58
Total Other Income/Expenses Net
687
537
334
Income Before Tax
-44,766
-41,064
-30,589
Income Tax Expense
42
38
26
Income from Continuing Operations
-44,808
-41,102
-30,615
Net Income
-44,808
-41,102
-30,615
Net Income available to common shareholders
-44,756
-41,050
-30,615
Reported EPS
Basic
-
-2.10
-1.57
Diluted
-
-2.10
-1.57
Weighted average shares outstanding
Basic
-
19,528
19,528
Diluted
-
19,528
19,528
EBITDA
-
-39,963
-30,063